[JAMA] Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk |
|
This post will be closed automatically in 2026-07-02 03:03
Reward20points
|
20
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk
20
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability每High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
10
Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion
10
Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion
20
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability每High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
